Real-time enrollment status for this clostridium difficile infection clinical trial
Current Status
Recruiting
Checked: July 17, 2026 at 4:22 AM UTC
| NCT Number | NCT07221370 |
| Recruiting Status | Recruiting |
| Condition | Clostridium Difficile Infection |
| Phase | PHASE2 |
| Target Enrollment | 176 participants |
| Active Locations | 1 sites in the US |
| Sponsor | Riverside University Health System Medical Center |
| Last Updated on CT.gov | November 10, 2025 (Nov 10, 2025) |
As of July 17, 2026: Clinical trial NCT07221370 is currently recruiting participants. This phase2 study for clostridium difficile infection is actively seeking new participants at 1 location across the United States. The study is sponsored by Riverside University Health System Medical Center. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07221370 is actively recruiting participants as of July 17, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 1 location in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07221370 was last updated Nov 10, 2025 (November 10, 2025). HelloStudys verifies this status automatically.